Search Results 61-70 of 17435 for ulcerative colitis

  1. Proctitis - Diagnosis & treatment - Mayo Clinic

    Proctitis caused by inflammatory bowel disease. Treatment of proctitis related to Crohn's disease or ulcerative colitis is aimed at reducing the inflammation in ...

  2. Long-Term Safety of PF-00547659 in Ulcerative Colitis - Mayo Clinic

    Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to ...

  3. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  4. Inflammatory bowel disease (IBD) - Care at Mayo Clinic

    ... ulcerative colitis. Mayo Clinic specializes in helping people with severe symptoms that haven't responded well to treatment in the past. Expertise. The ...

  5. A Study of the Relationship Between Infliximab Levels and the Rate of Colectomies in Patients who have Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess if infliximab drug levels in patients who have Ulcerative Colitis predict the risk of needing a colectomy. Additionally, ...

  6. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

    ... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.

  7. Mesalamine dose may lower marker of bowel inflammation Videos - Mayo Clinic

    A lower level of calprotectin is associated with a lower risk of having an ulcerative colitis flare. In inflammatory bowel disease (IBD), there can be a ...

  8. Mayo Clinic Q and A: Treating inflammatory bowel disease

    It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...

  9. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis · More about research at Mayo Clinic.

  10. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...